(Q54500829)

30 May 2018

title

Functional polymorphisms in ACE and CYP11B2 genes and atrial fibrillation in patients with hypertensive heart disease. (English)

1 reference

30 May 2018

0 references

Mingfang Huang

1

1 reference

30 May 2018

Xiaobo Gai

2

1 reference

30 May 2018

Xiangyue Yang

3

1 reference

30 May 2018

Jianping Hou

4

1 reference

30 May 2018

Xiaopeng Lan

5

1 reference

30 May 2018

Weixing Zheng

6

1 reference

30 May 2018

Fengping Chen

7

1 reference

30 May 2018

Jiake He

8

1 reference

30 May 2018

publication date

1 January 2009

1 reference

30 May 2018

Clinical Chemistry and Laboratory Medicine

published in

1 reference

30 May 2018

volume

47

1 reference

30 May 2018

issue

1

1 reference

30 May 2018

page(s)

32-37

1 reference

30 May 2018

Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates

cites work

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.023

Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.023

Atrial fibrillation in hypertension: predictors and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.023

Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.023

Enhanced cardiovascular morbidity and mortality during rhythm control treatment in persistent atrial fibrillation in hypertensives: data of the RACE study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.023

Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.023

Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.023

Renin-angiotensin system gene polymorphisms and atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.023

Effect of successful electrical cardioversion on serum aldosterone in patients with persistent atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.023

Mechanisms of mineralocorticoid action

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.023

Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.023

The regulation of aldosterone synthase expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.023

Aldosterone synthase (CYP11B2) polymorphisms and cardiovascular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.023

Aldosterone synthase gene polymorphism as a determinant of atrial fibrillation in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.023

Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.023

PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.023

Angiotensin II directly increases transforming growth factor beta1 and osteopontin and indirectly affects collagen mRNA expression in the human heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.023

Angiotensin II activates signal transducer and activators of transcription 3 via Rac1 in atrial myocytes and fibroblasts: implication for the therapeutic effect of statin in atrial structural remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.023

Mice with cardiac-restricted angiotensin-converting enzyme (ACE) have atrial enlargement, cardiac arrhythmia, and sudden death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.023

An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.023

Polymorphism in gene coding for ACE determines different development of myocardial fibrosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.023

Angiotensin-converting enzyme-gene polymorphism is associated with collagen I synthesis and QT dispersion in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.023

Disorders of aldosterone biosynthesis and action

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.023

Lone and secondary nonvalvular atrial fibrillation: Role of a genetic susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.023

21 January 2018

Identifiers

DOI

10.1515/CCLM.2009.023

1 reference

30 May 2018

1 reference

30 May 2018